vs
Side-by-side financial comparison of Brookfield Business Partners L.P. (BBU) and Colgate-Palmolive (CL). Click either name above to swap in a different company.
Brookfield Business Partners L.P. is the larger business by last-quarter revenue ($6.7B vs $5.3B, roughly 1.3× Colgate-Palmolive). Colgate-Palmolive runs the higher net margin — 12.1% vs 2.0%, a 10.1% gap on every dollar of revenue. On growth, Colgate-Palmolive posted the faster year-over-year revenue change (8.4% vs -44.0%).
Brookfield Business Partners L.P. is a publicly traded limited partnership and the primary public vehicle through which Brookfield Corporation, its parent company, owns and operates the business services and industrial operations of its private equity group. It was formed through a spin-off from Brookfield Asset Management in June 2016.
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
BBU vs CL — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.7B | $5.3B |
| Net Profit | $135.0M | $646.0M |
| Gross Margin | — | 60.6% |
| Operating Margin | — | 18.1% |
| Net Margin | 2.0% | 12.1% |
| Revenue YoY | -44.0% | 8.4% |
| Net Profit YoY | 107.7% | -6.4% |
| EPS (diluted) | $0.12 | $0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $5.3B | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | $6.7B | $5.1B | ||
| Q1 25 | — | $4.9B | ||
| Q4 24 | — | $4.9B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | $11.9B | $5.1B |
| Q1 26 | — | $646.0M | ||
| Q4 25 | — | $-36.0M | ||
| Q3 25 | — | $735.0M | ||
| Q2 25 | $135.0M | $743.0M | ||
| Q1 25 | — | $690.0M | ||
| Q4 24 | — | $738.0M | ||
| Q3 24 | — | $737.0M | ||
| Q2 24 | $65.0M | $731.0M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | 59.4% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 60.8% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 61.1% | ||
| Q2 24 | — | 60.6% |
| Q1 26 | — | 18.1% | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 21.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 21.6% |
| Q1 26 | — | 12.1% | ||
| Q4 25 | — | -0.7% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | 2.0% | 14.5% | ||
| Q1 25 | — | 14.1% | ||
| Q4 24 | — | 14.9% | ||
| Q3 24 | — | 14.6% | ||
| Q2 24 | 0.5% | 14.5% |
| Q1 26 | — | $0.80 | ||
| Q4 25 | — | $-0.04 | ||
| Q3 25 | — | $0.91 | ||
| Q2 25 | $0.12 | $0.91 | ||
| Q1 25 | — | $0.85 | ||
| Q4 24 | — | $0.89 | ||
| Q3 24 | — | $0.90 | ||
| Q2 24 | $-0.10 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3B | $1.3B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3B | — |
| Total Assets | $75.3B | $16.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $3.3B | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $3.0B | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | $7.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $54.0M | ||
| Q3 25 | — | $856.0M | ||
| Q2 25 | $15.3B | $702.0M | ||
| Q1 25 | — | $363.0M | ||
| Q4 24 | — | $212.0M | ||
| Q3 24 | — | $435.0M | ||
| Q2 24 | $18.2B | $123.0M |
| Q1 26 | — | $16.6B | ||
| Q4 25 | — | $16.3B | ||
| Q3 25 | — | $17.5B | ||
| Q2 25 | $75.3B | $17.5B | ||
| Q1 25 | — | $16.6B | ||
| Q4 24 | — | $16.0B | ||
| Q3 24 | — | $16.8B | ||
| Q2 24 | $81.5B | $16.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 145.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 33.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $609.0M |
| FCF MarginFCF / Revenue | — | 11.4% |
| Capex IntensityCapex / Revenue | — | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.8B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $884.0M | ||
| Q1 25 | — | $600.0M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $990.0M |
| Q1 26 | — | $609.0M | ||
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $776.0M | ||
| Q1 25 | — | $476.0M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $873.0M |
| Q1 26 | — | 11.4% | ||
| Q4 25 | — | 24.4% | ||
| Q3 25 | — | 21.6% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 9.7% | ||
| Q4 24 | — | 21.9% | ||
| Q3 24 | — | 20.5% | ||
| Q2 24 | — | 17.3% |
| Q1 26 | — | 2.6% | ||
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 1.19× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 1.72× | ||
| Q3 24 | — | 1.58× | ||
| Q2 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBU
Segment breakdown not available.
CL
| Latin America | $1.3B | 25% |
| Pet Nutrition | $1.2B | 22% |
| Europe, Middle East & Africa (1) | $1.1B | 21% |
| North America (1) | $888.0M | 17% |
| Asia Pacific (1) | $804.0M | 15% |
